Life Sciences Manufacturing Automation & Validation

Compliance-Safe Automation Modernization for Regulated Life Sciences Facilities

Modernizing automation within life sciences manufacturing requires more than technical capability, it requires deep understanding of regulated production environments.

IPS supports life sciences manufacturers with automation modernization, validation documentation, and manufacturing data intelligence solutions that improve operational performance while maintaining full compliance with regulatory expectations.

Our work is structured around GMP alignment, data integrity principles, and audit ready execution.

Who We Are

    • Aging PLC and SCADA infrastructure

    • Validation documentation backlogs

    • Data integrity risk exposure

    • Automation driven audit findings

    • Limited internal validation bandwidth

    • Modernization hesitation due to compliance risk

      Modernization must strengthen compliance, not threaten it.

      Upgrades must be structured, validated, and production safe.

  • IPS works across regulated life sciences manufacturing sectors, including:

    Pharmaceutical Manufacturing

    Sterile manufacturing, fill-finish operations, solid dose production, and packaging systems.

    Biotechnology & Biologics Production

    Bioprocessing systems, biologics manufacturing environments, and advanced therapeutic production.

    Medical Device Manufacturing

    Automation and manufacturing systems supporting regulated device production and assembly environments.

    Contract Development & Manufacturing Organizations (CDMOs)

    Facilities supporting outsourced pharmaceutical and biotechnology manufacturing operations.

    • Strict regulatory oversight

    • GMP-compliant production environments

    • Extensive validation documentation requirements

    • High expectations for data integrity and traceability

    • Increasing pressure to modernize legacy automation systems

    IPS specializes in executing modernization programs within these regulated manufacturing environments.

  • If an audit is approaching or recent findings require remediation, we provide:

    • Electronic batch reporting systems

    • Historian data consolidation

    • OEE dashboards for regulated production

    • Compliance aligned reporting architecture

    We reduce risk before inspections.

The Reality Inside Life Sciences Manufacturing Facilities

Manufacturers across the life sciences sector face increasing operational and regulatory pressure.

Common challenges include:

  • Aging PLC, HMI, and SCADA infrastructure

  • Documentation backlogs resulting from previous system changes

  • Data integrity exposure within legacy systems

  • Audit findings related to automation validation gaps

  • Limited internal validation bandwidth

  • Organizational hesitation to modernize due to compliance risk

Automation upgrades cannot compromise compliance.

System changes must be structured, validated, and production safe.

Our core capabilities

Validation Documentation & Remediation

IPS delivers structured validation support aligned with regulated manufacturing environments.

Our services include:

  • Validation Plans and Validation Master Plans

  • User Requirements Specifications (URS)

  • Functional and Design Specifications (FS / DS)

  • Configuration Specifications (CS)

  • Risk Assessments (GAMP-based)

  • Requirements Traceability Matrices (RTM)

  • IQ / OQ / PQ protocol development and execution

  • Validation Summary Reports (VSR)

  • Change control documentation

  • Validation gap assessments

  • Audit remediation programs

Our objective is to close validation gaps efficiently while strengthening long-term compliance posture.

Automation Modernization (Compliance Embedded)

IPS supports modernization of critical manufacturing automation systems including:

  • PLC control systems

  • HMI operator interfaces

  • SCADA platforms

  • Batch control systems

  • Packaging line automation

Every modernization program includes:

  • Integrated validation planning

  • Documentation development alongside implementation

  • Phased migration strategies to minimize production disruption

Our approach enables controlled modernization without operational instability.

Manufacturing Data Intelligence & Batch Reporting

Data collection alone does not create compliance or operational clarity.

IPS implements systems that transform manufacturing data into structured, audit-ready operational insight.

Capabilities include:

  • Automated batch reporting systems

  • Historian data consolidation

  • Audit-ready traceability dashboards

  • OEE dashboards for regulated production

  • Compliance monitoring tools

These solutions provide clear operational visibility aligned with GMP expectations.

Audit Readiness & Stabilization Programs

When regulatory inspections are approaching or recent findings require remediation rapid corrective action may be required.

IPS provides focused remediation programs including:

  • Documentation backlog recovery

  • System validation reviews

  • Data integrity remediation support

  • Short-duration remediation sprints

Our focus is reducing compliance exposure before inspections occur.

How We Execute Without Production Disruption

Automation modernization must not create operational instability.

IPS follows a structured execution framework:

  • System assessment and risk analysis

  • Parallel validation documentation development

  • Controlled implementation planning

  • Validation-first system deployment

  • Structured commissioning and qualification

  • Post-implementation stabilization

This approach ensures controlled system evolution rather than uncontrolled upgrades.

Typical Client Engagements

IPS commonly supports life sciences manufacturers with:

  • Legacy PLC replacement planning

  • SCADA modernization roadmaps

  • Validation remediation following system changes

  • Packaging line automation upgrades

  • Batch reporting and production visibility improvements

  • Compliance documentation backlog recovery

  • OEE implementation within regulated manufacturing environments

Why Life Sciences Manufacturers Work With IPS

Key differentiators include:

  • Compliance-first engineering mindset

  • Validation integrated directly into modernization programs

  • Production disruption minimized through structured migration strategies

  • Strong documentation discipline aligned with GMP expectations

  • Multinational engineering coordination model

  • Executive-level oversight of project delivery

    Our focus is risk reduction, operational stability, and long-term system sustainability.

Engagement Models

IPS provides structured engagement options including:

  • Fixed-scope validation packages

  • Automation modernization assessments

  • Audit remediation programs

  • Retainer-based compliance support

Each engagement is delivered with defined scope, structured milestones, and transparent deliverables.

Frequently Asked Questions

  • Yes. IPS engagements are structured specifically for regulated life sciences manufacturing and align with GMP and audit readiness requirements.


  • Yes. Our phased migration strategies are designed to minimize production disruption while maintaining validation compliance.